<code id='3A6AB6DE41'></code><style id='3A6AB6DE41'></style>
    • <acronym id='3A6AB6DE41'></acronym>
      <center id='3A6AB6DE41'><center id='3A6AB6DE41'><tfoot id='3A6AB6DE41'></tfoot></center><abbr id='3A6AB6DE41'><dir id='3A6AB6DE41'><tfoot id='3A6AB6DE41'></tfoot><noframes id='3A6AB6DE41'>

    • <optgroup id='3A6AB6DE41'><strike id='3A6AB6DE41'><sup id='3A6AB6DE41'></sup></strike><code id='3A6AB6DE41'></code></optgroup>
        1. <b id='3A6AB6DE41'><label id='3A6AB6DE41'><select id='3A6AB6DE41'><dt id='3A6AB6DE41'><span id='3A6AB6DE41'></span></dt></select></label></b><u id='3A6AB6DE41'></u>
          <i id='3A6AB6DE41'><strike id='3A6AB6DE41'><tt id='3A6AB6DE41'><pre id='3A6AB6DE41'></pre></tt></strike></i>

          leisure time

          leisure time

          author:hotspot    Page View:27
          Adobe

          Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

          Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

          advertisement

          When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          The haunting brain science of long Covid
          The haunting brain science of long Covid

          AdobeMattFitzgeraldusedtobikeupanddown3,500feetthroughtheSantaAnaMountainsonthree-hourridesjustforfu

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          Will the FTC rein in IQVIA's health data empire?

          AdobeThehealthdatagiantIQVIAbecameadominantforcebygobblingupitsrivals.Overdecades,itfeastedonupstart